Education
About Us
Working with TipRanks
Follow Us
Ardent Health Partners, Inc. (ARDT)
NYSE:ARDT
RESEARCH TOOLSreports
Earnings Data
Report Date
Aug 13, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.58Last Year’s EPS
0.34Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 06, 2025
|% Change Since: 4.15%
|Next Earnings Date:Aug 13, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong admissions growth, revenue increase, operational cost improvements, and a credit rating upgrade. However, there were challenges such as increased payer claim denials, a decline in outpatient surgeries, and the impact of oncology service transfers. Despite these challenges, the company remains optimistic about its strategic growth initiatives.Company Guidance
During the first quarter of 2025, Ardent Health Partners reported a strong financial and operational performance, with key metrics indicating positive growth trends. Admissions increased by 7.6%, while adjusted admissions grew by 2.7%, aligning with the company's full-year outlook of 2% to 3%. Inpatient surgeries saw a growth of 3.4%, and first-quarter revenue rose by 4% to $1.5 billion. Net patient service revenue per adjusted admission grew by 1.2%, despite a 70 basis point headwind from transferring certain oncology and infusion services. Adjusted EBITDA increased by 2.5% to $98 million, supported by improvements in supply chain efficiency, resulting in a 60 basis point reduction in supply costs as a percentage of revenue. Ardent ended the quarter with $495 million in cash and a lease-adjusted net leverage ratio of 3 times, reaffirming its full-year 2025 financial guidance.Strong Admissions Growth
Admissions grew 7.6% driven by strong underlying growth and heightened flu season, with inpatient surgery growth of 3.4%.
Revenue and EBITDA Increase
First-quarter revenue increased 4% to $1.5 billion. Adjusted EBITDA grew 2.5% to $98 million.
Operational Cost Improvements
Supply costs as a percent of revenue declined 60 basis points year-over-year, with expectations of further margin improvements by 100 to 200 basis points over the next three to four years.
Credit Rating Upgrade
S&P upgraded Ardent Health's credit rating to B+ from B, reflecting improved net leverage and cash flow profile.
Successful Integration of NextCare Clinics
Integration of 18 NextCare urgent care clinics is expected to generate additional downstream volumes in Tulsa and Albuquerque markets.
ARDT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ARDT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2025 | $13.01 | $14.21 | +9.22% |
Feb 26, 2025 | $14.01 | $15.16 | +8.21% |
Nov 06, 2024 | $16.27 | $17.54 | +7.81% |
Aug 14, 2024 | $16.00 | $16.97 | +6.06% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ardent Health Partners, Inc. (ARDT) report earnings?
Ardent Health Partners, Inc. (ARDT) is schdueled to report earning on Aug 13, 2025, TBA Not Confirmed.
What is Ardent Health Partners, Inc. (ARDT) earnings time?
Ardent Health Partners, Inc. (ARDT) earnings time is at Aug 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ARDT EPS forecast?
ARDT EPS forecast for the fiscal quarter 2025 (Q2) is 0.58.